These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22199321)

  • 1. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
    Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S
    Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis.
    Gottschling S; Jensen K; Warth A; Herth FJ; Thomas M; Schnabel PA; Herpel E
    Eur Respir J; 2013 Mar; 41(3):656-63. PubMed ID: 22743677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
    Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E
    Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
    Li F; Zeng H; Ying K
    Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP).
    Gottschling S; Herpel E; Eberhardt WE; Heigener DF; Fischer JR; Köhne CH; Kortsik C; Kuhnt T; Muley T; Meister M; Bischoff HG; Klein P; Moldenhauer I; Schnabel PA; Thomas M; Penzel R
    Lung Cancer; 2012 Jul; 77(1):183-91. PubMed ID: 22483783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
    Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
    Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis.
    Wang W; Chen Y; Deng J; Zhou J; Zhou Y; Wang S; Zhou J
    Tumour Biol; 2014 Oct; 35(10):9769-75. PubMed ID: 24973892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
    Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q; Zhang X; Deng T; Gao J
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of CD133 and endothelin-converting enzyme expressions with prognosis of non-small cell lung carcinoma].
    Zhang HZ; Wei YP; Wang M; Wu C; Yang YQ; Chen J; Cao YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):696-9. PubMed ID: 17545092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer.
    Huang M; Zhu H; Feng J; Ni S; Huang J
    Dis Markers; 2015; 2015():986095. PubMed ID: 25691807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer.
    Gottschling S; Schnabel PA; Herth FJ; Herpel E
    Cancer Genomics Proteomics; 2012; 9(5):275-86. PubMed ID: 22990107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.
    Li W; Tamamura R; Wang B; Liu Q; Liu H; Liu T; Katase N; Xiao J; Nagatsuka H
    Biomed Res Int; 2014; 2014():132349. PubMed ID: 24804195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.